Comprehensive Frailty Assessment
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 111
- Locations
- 1
- Primary Endpoint
- Change in Comprehensive Frailty Assessment
Study Overview
Brief Summary
The purpose of this research study is to describe a patients' fitness before and after treatment (whether that treatment be chemotherapy or a transplant). Fitness is a way of measuring a patient's current quality of health. With surveys, questionnaires and blood tests, we hope to create a tool that will give a good picture of patients' ability to tolerate treatment. In the future, we hope to devise the best treatment for a patient based on their "fitness".
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •patients with a plasma cell dyscrasia AND/OR any patient receiving a stem cell transplant for a hematologic malignancy at The Ohio State University
- •at least 18 years of age
Exclusion Criteria
- •Any medical or psychiatric condition that would make it difficult for the patient to comply with study procedures.
Outcomes
Primary Outcomes
Change in Comprehensive Frailty Assessment
Time Frame: up to 14 months
Responses to the Comprehensive Frailty Assessment will be assessed before and after treatment and changes will be evaluated. In transplant patients, this will be measured one year post transplant and in the non-transplant arm, this will be assessed after the second cycle of treatment.
Secondary Outcomes
- Time to progression(date of enrollment to date of documented clinical progression up to two years post-enrollment)
Investigators
Ashley Rosko
Principal Investigator
Ohio State University Comprehensive Cancer Center